| __timestamp | Intra-Cellular Therapies, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 22223073 |
| Thursday, January 1, 2015 | 87718074 | 6966842 |
| Friday, January 1, 2016 | 93831530 | 9000499 |
| Sunday, January 1, 2017 | 79419009 | 13741186 |
| Monday, January 1, 2018 | 132166913 | 19040000 |
| Tuesday, January 1, 2019 | 89124838 | 23559000 |
| Wednesday, January 1, 2020 | 65782137 | 31931000 |
| Friday, January 1, 2021 | 88845513 | 44981000 |
| Saturday, January 1, 2022 | 134715000 | 54234000 |
| Sunday, January 1, 2023 | 180142000 | 63806000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Viking Therapeutics, Inc. have been at the forefront of this race. From 2014 to 2023, Intra-Cellular Therapies has consistently outpaced Viking Therapeutics in R&D investment, with a staggering 180% increase in spending, peaking at $180 million in 2023. In contrast, Viking Therapeutics, while showing a steady growth, reached $64 million in the same year, marking a 187% rise since 2014. This disparity highlights Intra-Cellular's aggressive push towards groundbreaking therapies, while Viking's more measured approach reflects its strategic focus on targeted innovations. As these companies continue to evolve, their R&D trajectories offer a fascinating glimpse into the future of biotech advancements.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development Expenses Breakdown: argenx SE vs Intra-Cellular Therapies, Inc.
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Viking Therapeutics, Inc. vs Bausch Health Companies Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?